The proposed diagnostic category of “low‐risk oncocytic renal neoplasm” consists of both oncocytomas and a subset of chromophobe renal cell carcinomas but has a 5‐year survival of at least 95%–100%.
No takes yet. Share an insight, caveat, or question.
Renshaw et al. (2023) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: